Avita Medical Inc (RCEL) Stock Price, Quote & News

Company Profile

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to...

Industry: Medical Devices

Sector: Healthcare

Phone: 661 367 9170

Fax: 661 749 9430

Website: avitamedical.com

Address:

28159 Avenue Stanford, Suite 220, Valencia, United States

StocksWithFlav Jan. 14 at 12:58 AM

$RCEL someone wanted in before 8PM close

0 · Reply

bigbulldaddy Jan. 14 at 12:33 AM

$MDXG $RCEL $SOLV $VCEL I don’t think SOLV. We just bought restrata… we don’t need RCEL. Our teams could easily sell it into burn centers though.

0 · Reply

alexpitti Jan. 13 at 6:36 PM

$RCEL replaced old debt with new debt and added a bit more cash. the full year guidance is fine, but Q1 looks to be a decline. this is not a good investment

1 · Reply

BeefStewart Jan. 13 at 5:44 PM

$RCEL today's update seems very positive... Any thoughts?

1 · Reply

BeefStewart Jan. 12 at 10:43 PM

$RCEL @GoldmanSlaps @techjerk @OldManLogan @Me0wth any thoughts on this one at these levels? Cash runway seems to be the biggest concern here, but the potential seems huge. Watching... 🎩🧐

2 · Reply

BeefStewart Jan. 12 at 10:36 PM

$RCEL Anyone still here and feeling hopeful? This had such huge potential... Any pathway forward that doesn't require dilution?

0 · Reply

mgm1069 Jan. 11 at 1:52 AM

$RCEL Cohealyx study has closed enrollment with 41 participants.. data should be available soon https://clinicaltrials.gov/study/NCT06787690

0 · Reply

JHR Jan. 8 at 6:04 PM

$SNN aquire me. I need aquiring now. We give good price 👍 $RCEL

0 · Reply

JHR Jan. 8 at 5:53 PM

$RCEL Who is going to acquire $RCEL in late 2026? $SOLV $MDXG $VCEL

0 · Reply

TrkDvr Jan. 8 at 4:08 PM

$RCEL I know its bad form to brag but I sold this stock a year ago at $9 for a profit and purchased it back for $3.27 this wk. Could my luck have turned!

1 · Reply

AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook

Jan 5, 2026, 4:05 PM EST - 8 days ago

AVITA Medical Announces Changes to its Board of Directors

Dec 18, 2025, 4:15 PM EST - 26 days ago

AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

Nov 24, 2025, 4:15 PM EST - 7 weeks ago

AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference

Nov 12, 2025, 8:51 PM EST - 2 months ago

AVITA Medical, Inc. (RCEL) Discusses Advanced Wound Care Solutions and Data-Driven Approaches in Clinical Healing Transcript

Nov 6, 2025, 8:06 PM EST - 2 months ago

AVITA Medical, Inc. (RCEL) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 8:30 AM EST - 2 months ago

Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment

Oct 29, 2025, 4:15 PM EDT - 2 months ago

AVITA Medical to Announce Third Quarter 2025 Financial Results

Oct 28, 2025, 4:30 PM EDT - 2 months ago

AVITA Medical Welcomes Support for RECELL® in Burns in Australia

Oct 16, 2025, 6:15 PM EDT - 3 months ago

AVITA Medical Announces CEO Transition

Oct 16, 2025, 5:43 PM EDT - 3 months ago

AVITA MEDICAL INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders

Oct 9, 2025, 12:49 PM EDT - 3 months ago

AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders

Oct 1, 2025, 8:30 AM EDT - 3 months ago

CMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute Wounds

Sep 18, 2025, 7:30 AM EDT - 4 months ago

AVITA Medical: Reimbursement Reset And Breakeven Path By 2026

Sep 11, 2025, 3:31 PM EDT - 4 months ago

RCEL Investors Have Opportunity to Join AVITA Medical, Inc. Fraud Investigation with the Schall Law Firm

Sep 9, 2025, 3:47 PM EDT - 4 months ago

AVITA Medical, Inc. Investors: Company Investigated by the Portnoy Law Firm

Sep 8, 2025, 6:23 PM EDT - 4 months ago

AVITA Medical, Inc. (RCEL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Aug 21, 2025, 4:05 PM EDT - 5 months ago

AVITA Medical Announces September Investor Conference Participation

Aug 12, 2025, 8:30 AM EDT - 5 months ago

AVITA Medical Successfully Completes Australian Equity Raise

Aug 10, 2025, 7:00 PM EDT - 5 months ago

AVITA Medical to Host Investor Webinar Briefing

Aug 8, 2025, 3:21 PM EDT - 5 months ago

AVITA Medical, Inc. (RCEL) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 5 months ago

AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation

Jul 28, 2025, 4:05 PM EDT - 6 months ago

AVITA Medical to Announce Second Quarter 2025 Financial Results

Jun 3, 2025, 8:00 PM EDT - 8 months ago

AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards

May 8, 2025, 9:50 PM EDT - 8 months ago

AVITA Medical, Inc. (RCEL) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:03 PM EDT - 8 months ago

AVITA Medical Reports First Quarter 2025 Financial Results

Apr 17, 2025, 4:05 PM EDT - 9 months ago

AVITA Medical to Announce First Quarter 2025 Financial Results

Apr 9, 2025, 4:05 PM EDT - 9 months ago

AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025

Apr 3, 2025, 4:03 PM EDT - 10 months ago

AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity

Mar 17, 2025, 4:05 PM EDT - 10 months ago

AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific

Feb 26, 2025, 5:30 PM EST - 11 months ago

AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference

Feb 18, 2025, 12:01 PM EST - 11 months ago

After Sales Rebound In January, AVITA Is Set Up For A Monster Year

Feb 13, 2025, 9:33 PM EST - 11 months ago

AVITA Medical, Inc. (RCEL) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 4:01 PM EST - 11 months ago

AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results

Jan 12, 2025, 10:52 PM EST - 1 year ago

Investors Burned By AVITA Medical's Sales Miss: I'm Even More Bullish

Jan 10, 2025, 6:28 PM EST - 1 year ago

AVITA Medical: A Dip Buy As 2025 Looks Bullish With Cohealyx And RECELL GO Mini

Jan 8, 2025, 1:06 PM EST - 1 year ago

Avita Medical Cuts Annual Sales Forecast On Softer Demand From Hospitals

Jan 8, 2025, 8:14 AM EST - 1 year ago

AVITA Medical, Quantum Computing And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Jan 7, 2025, 10:12 PM EST - 1 year ago

AVITA Medical's shares sink 19% after another forecast cut

Jan 7, 2025, 4:35 PM EST - 1 year ago

AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance

Jan 2, 2025, 11:26 AM EST - 1 year ago

AVITA Medical Just Tripled Its TAM In The Burn Market

Dec 23, 2024, 4:02 PM EST - 1 year ago

AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds

Dec 19, 2024, 5:05 PM EST - 1 year ago

AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market

StocksWithFlav Jan. 14 at 12:58 AM

$RCEL someone wanted in before 8PM close

0 · Reply

bigbulldaddy Jan. 14 at 12:33 AM

$MDXG $RCEL $SOLV $VCEL I don’t think SOLV. We just bought restrata… we don’t need RCEL. Our teams could easily sell it into burn centers though.

0 · Reply

alexpitti Jan. 13 at 6:36 PM

$RCEL replaced old debt with new debt and added a bit more cash. the full year guidance is fine, but Q1 looks to be a decline. this is not a good investment

1 · Reply

BeefStewart Jan. 13 at 5:44 PM

$RCEL today's update seems very positive... Any thoughts?

1 · Reply

BeefStewart Jan. 12 at 10:43 PM

$RCEL @GoldmanSlaps @techjerk @OldManLogan @Me0wth any thoughts on this one at these levels? Cash runway seems to be the biggest concern here, but the potential seems huge. Watching... 🎩🧐

2 · Reply

BeefStewart Jan. 12 at 10:36 PM

$RCEL Anyone still here and feeling hopeful? This had such huge potential... Any pathway forward that doesn't require dilution?

0 · Reply

mgm1069 Jan. 11 at 1:52 AM

$RCEL Cohealyx study has closed enrollment with 41 participants.. data should be available soon https://clinicaltrials.gov/study/NCT06787690

0 · Reply

JHR Jan. 8 at 6:04 PM

$SNN aquire me. I need aquiring now. We give good price 👍 $RCEL

0 · Reply

JHR Jan. 8 at 5:53 PM

$RCEL Who is going to acquire $RCEL in late 2026? $SOLV $MDXG $VCEL

0 · Reply

TrkDvr Jan. 8 at 4:08 PM

$RCEL I know its bad form to brag but I sold this stock a year ago at $9 for a profit and purchased it back for $3.27 this wk. Could my luck have turned!

1 · Reply

alexpitti Jan. 8 at 4:13 AM

avita will give full year guidance 2026 $RCEL in the next few days

0 · Reply

alexpitti Jan. 7 at 8:52 PM

$RCEL avita only has 4 MACs out of 7. So Q1 is looking challenged

1 · Reply

mgm1069 Jan. 2 at 12:02 AM

$RCEL Recell on day 54.. getting used in every tough case https://www.cureus.com/articles/437711-a-traumatic-loss-of-the-calcaneus-and-heel-pad-from-a-lawnmower-injury-in-a-pediatric-patient-a-case-report#!/

1 · Reply

WorldShakerLuke Dec. 30 at 11:02 PM

$RCEL Took the tax loss, will rebuy in 30 days

0 · Reply

mgm1069 Dec. 28 at 5:33 PM

$RCEL https://www.bucksfreepress.co.uk/news/25723776.stoke-mandeville-hospital-first-uk-use-recell-go/

0 · Reply

BiometricsB3 Dec. 26 at 4:52 PM

$RCEL Conditions are shifting toward markets rewarding operational proof over narrative ambition. Governance alignment should reduce uncertainty over time. Overextension would degrade optionality during downturns. The trajectory strengthens as results compound visibly.

1 · Reply

SuperGreenToday Dec. 23 at 11:48 PM

$RCEL Share Price: $3.45 Contract Selected: Jul 17, 2026 $2.5 Calls Buy Zone: $0.89 – $1.10 Target Zone: $1.54 – $1.88 Potential Upside: 63% ROI Time to Expiration: 205 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

mgm1069 Dec. 22 at 2:09 PM

$RCEL https://academic.oup.com/milmed/advance-article-abstract/doi/10.1093/milmed/usaf599/8385304?redirectedFrom=fulltext

0 · Reply

StonkGoblin5 Dec. 20 at 5:01 PM

$RCEL small biotech stuck mid range, higher lows plus a break through resistance on strong volume could signal real rerate

0 · Reply

JHR Dec. 16 at 4:48 PM

$RCEL

0 · Reply

mgm1069 Dec. 9 at 10:21 PM

$RCEL https://www.cureus.com/articles/439017-bovine-dermal-collagen-matrix-for-early-graft-readiness-in-a-full-thickness-posterior-neck-burn-a-case-report?score_article=true#!/

1 · Reply

HexBinance Dec. 4 at 5:23 PM

$CLSK I have the self-awareness to understand that I'm probably most likely talking to no one other than myself here but if I gained any faith with $ARMP ( stay in there and put more in when you're comfortable) please let me Direct some of your attention over to $RCEL. I'm not a wizard I don't know the future, but I take my time and I only invest in things I have 100% concrete evidence of. Long term very valuable short-term it's a steal.

2 · Reply

Market Cap	104.29M
Revenue (ttm)	64.25M
Net Income (ttm)	-61.85M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-96.26%
Debt to Equity Ratio	-6.36

Volume	181,700
Avg Vol	209,464
Day's Range	N/A - N/A
Shares Out	30.49M
Stochastic %K	21%
Beta	1.70
Analysts	Sell
Price Target	$7.88